Initially, activated EGFR signaling, via the downstream Extracellular Regulated Protein Kinases (ERK) pathway, not only promotes the secretion of the VEGF ligand but also upregulates the expression of VEGF receptors on the surface of the tumor cells themselves. Here, EGFR is linked to neoplasm.